Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (481-490 of 560) with videos related to

Pageof 56
Sort By:
Blood|May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
Journal of Translational Medicine|September 30, 2022
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarizationDomenico Mallardo, Ester Simeone, Vito Vanella, et al.
NPJ Breast Cancer|June 13, 2023
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapyGina Kim, Burcu Karadal-Ferrena, Jiyue Qin, et al.
JCO Global Oncology|July 23, 2020
Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming BarriersLilie L Lin, David S Lakomy, Elizabeth Y Chiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2018
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102Noah Kornblum, Fengmin Zhao, Judith Manola, et al.
JAMA Network Open|July 3, 2025
Quality of Life Among Patients With Ductal Carcinoma In SituVictoria J Dunsmore, Bradley S Snyder, Ilana F Gareen, et al.
Blood|December 22, 2009
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
The Lancet. Oncology|November 28, 2017
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trialSara A Hurvitz, Miguel Martin, W Fraser Symmans, et al.
The Breast Journal|July 5, 2012
Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotypingGordon F Schwartz, Harry Bartelink, Harold J Burstein, et al.
Journal of the National Cancer Institute|September 22, 2018
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast CancerJinani Jayasekera, Clyde B Schechter, Joseph A Sparano, et al.
Pageof 56

Showing results (481-490 of 560) with videos related to

Sort By:
Pageof 56
Blood|May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
Journal of Translational Medicine|September 30, 2022
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarizationDomenico Mallardo, Ester Simeone, Vito Vanella, et al.
NPJ Breast Cancer|June 13, 2023
Racial disparity in tumor microenvironment and distant recurrence in residual breast cancer after neoadjuvant chemotherapyGina Kim, Burcu Karadal-Ferrena, Jiyue Qin, et al.
JCO Global Oncology|July 23, 2020
Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming BarriersLilie L Lin, David S Lakomy, Elizabeth Y Chiao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2018
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102Noah Kornblum, Fengmin Zhao, Judith Manola, et al.
JAMA Network Open|July 3, 2025
Quality of Life Among Patients With Ductal Carcinoma In SituVictoria J Dunsmore, Bradley S Snyder, Ilana F Gareen, et al.
Blood|December 22, 2009
Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphomaJoseph A Sparano, Jeannette Y Lee, Lawrence D Kaplan, et al.
The Lancet. Oncology|November 28, 2017
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trialSara A Hurvitz, Miguel Martin, W Fraser Symmans, et al.
The Breast Journal|July 5, 2012
Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotypingGordon F Schwartz, Harry Bartelink, Harold J Burstein, et al.
Journal of the National Cancer Institute|September 22, 2018
Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast CancerJinani Jayasekera, Clyde B Schechter, Joseph A Sparano, et al.
Pageof 56